Alk-positive Non-small Cell Lung Cancer

• CLINICAL_TRIALS trial_result · 2026-04-14
  Clinical Trial Update: A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC [Phase 1, Phase 2]

  A Phase 1/2 clinical trial evaluating TRI-611 for ALK-positive non-small cell lung cancer is currently recruiting.

• CLINICAL_TRIALS trial_result · 2026-04-07
  Clinical Trial Update: Expanded Access Program of Neladalkib (NVL-655) for Patients With Advanced ALK+ NSCLC or Other ALK+ Solid Tumors

  This update announces the availability of an Expanded Access Program for Neladalkib (NVL-655) for patients with advanced ALK-positive non-sm…

• CLINICAL_TRIALS trial_result · 2026-03-27
  Clinical Trial Update: Post Marketing Surveillance(PMS) Study of Lorviqua in Korea

  A post-marketing surveillance study of Lorviqua (lorlatinib) in Korea for metastatic ALK-positive non-small cell lung cancer is currently re…

• CLINICAL_TRIALS trial_result · 2025-02-25
  Clinical Trial Update: Chemotherapy Combined with ICIs in First-line Alectinib Failed Patients with ALK-rearranged NSCLC [Phase 2]

  Phase 2 clinical trial update evaluating chemotherapy combined with immune checkpoint inhibitors in ALK-rearranged non-small cell lung cance…

• CLINICAL_TRIALS trial_result · 2024-10-16
  Clinical Trial Update: Post-Market Surveillance Study of ALK-Positive Advanced NSCLC Participants Treated With Iruplinalkib

  Post-market surveillance clinical trial evaluating ALK-positive advanced non-small cell lung cancer patients treated with Iruplinalkib; the …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2024-05-10
  Clinical Trial Update: A Retrospective Study of the Efficacy and Safety of Lolatinib in ALK+ NSCLC Patients With Brain or Meningeal Metastasis

  A retrospective study evaluating the efficacy and safety of Lolatinib in ALK-positive non-small cell lung cancer patients with brain metasta…

• CLINICAL_TRIALS trial_result · 2024-04-26
  Clinical Trial Update: Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib [Phase 2]

  A Phase 2 trial of Alkotinib capsules in ALK-positive non-small cell lung cancer patients previously treated with Crizotinib has been termin…

• CLINICAL_TRIALS trial_result · 2024-04-05
  Clinical Trial Update: Study to Evaluate Clinical Real World Outcomes of Lorlatinib After Alectinib in ALK-Positive NSCLC Japanese Patients

  A completed clinical trial evaluating real-world outcomes of lorlatinib after alectinib in ALK-positive non-small-cell lung cancer patients …